SummaryIn the US, LDCT was linked to a 16% lower risk of lung cancer death at 7 years, while a European trial found lower mortality among men screened with LDCT at 10 years. Dr Abhishek Shankar said India needs its own screening evidence and access to screening and follow-up care for high-risk people.